WHO International Standards /Reference Reagents Submission to ECBS of post-establishment stability monitoring/stability evaluation

WHO/BS/10.2135 ENGLISH ONLY

EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 18 to 22 October 2010

WHO International Standards /Reference Reagents

Submission to ECBS of post-establishment stability monitoring/stability evaluation

2

IS somatropin (rec human growth hormone) Dr. A. Bristow

National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Herts, EN6 3QG, UK

© World Health Organization 2010

All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail:

[email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e- mail: [email protected]).

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.

Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. The named authors alone are responsible for the views expressed in this publication.

WHO/BS/10.2135 Page 2

WHO International Standards /Reference Reagents

Submission to ECBS of post-establishment stability monitoring/stability evaluation

2

IS somatropin (rec human growth hormone)

Code 98/574

Project leader A. Bristow

Date of evaluation May 2009

Date of establishment 2000

Principle application(s) Primary: Physico-chemical assays for rec hGH

Secondary: Bioassays sing conventional specific activity Secondary: Immunoassays

Summary of Stability data obtained at establishment

6 month accelerated degradation study

No measurable loss of somatropin monomer at

temperatures below 45deg, therefore no predicted loss of activity.

Predicted loss of HPLC purity – 0.017%.year at -20

ECBS notes/follow-up recommendations at establishment

Committee noted that stability will continue to be monitored in real time

Summary of post establishment stability evaluation

At 11 years post-fill, ampouled materials (stored at -20) compared with Frozen baselines stored continuously at - 150deg.

No differences in:

- Monomer content (predicted biological activity) - RP HPLC purity profile

Recommendation for ECBS endorsement

ECBS is asked to note that real time stability studies have confirmed predictions at time of establishment

Proposed date of further

evaluation 2018 (20 yeas post fill) or on replacement, whichever is sooner

= = =